Showing 1-8 of 8 grants

Title Institution Researcher Program Duration Total Award Amount
Genetic dissection of GLP1R signaling in type 1 diabetes outcomes Yale University David Alagpulinsa Improving Lives 01-April-2026 to 31-March-2027 $180.829,34
Genetic variation in RPS26 modulates beta-cell vitality and immunogenicity in type 1 diabetes Yale University David Alagpulinsa Cures 01-April-2026 to 31-March-2027 $199.959,68
Immune-cell targeted TLR7 antagonist to halt the attack on beta−cells in the context of Type 1 Diabetes Tezcat Bio Craig Ramirez Cures 15-January-2026 to 31-December-2026 $100.000,00
Understanding Role of B cells in the pathogenesis of Type 1 Diabetes and Multiple Sclerosis Yale University Yoshiaki Yasumizu Cures 01-September-2025 to 31-August-2026 $149.191,66
Home-based oral glucose tolerance test for type 1 diabetes screening Yale University Jennifer Sherr Cures 01-April-2025 to 31-March-2027 $347.849,00
Harnessing hematopoietic function in acute lymphoblastic leukemia to treat type 1 diabetes Yale University David Alagpulinsa Cures 01-March-2025 to 28-February-2030 $991.634,17
Engineering inflammation resistant beta cells Yale University Kevan Herold Cures 01-September-2023 to 31-August-2026 $499.999,37
Phenotyping RElatives of persons with Diabetes with CGM and Tests of beta-cell function and health (PREDICT): an integrated longitudinal assessment of deep metabolic phenotyping and CGM metrics in youth at risk for T1D Yale University Alfonso Galderisi Cures 01-February-2023 to 30-September-2026 $747.380,88